Paper-based microfluidics for diagnostics and environmental monitoring are being developed by startups.
The interest in microfluidics in the BioTech industry stems from the need for lab-on-a-chip (LOC) devices. These miniaturized labs enable affordable, swift testing of infectious diseases, paving the way for point-of-care diagnostics. Paper-based microfluidics for diagnostics and environmental monitoring are being developed by startups. Organ-on-a-chip (OOC) devices, simulating organ physiology on small chips, find applications in drug screening and disease modeling.